Startup profile · funding coverage
RxVantage funding, valuation and investors
Platform connecting healthcare providers with life science professionals for education and access scheduling.
Keep track of RxVantage
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Not publicly disclosed
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · Providence, RI
Overview
RxVantage provides software that helps healthcare organizations manage interactions with life science industry professionals. Headquarters listed at 225 Dyer St, Providence, Rhode Island 02903. Privately held; multi-office U.S. presence including California.
Why RxVantage is interesting
Providence healthtech SaaS with HQ at 225 Dyer St — Slater-adjacent commercialization story.
Product & use cases
Scheduling/engagement software for industry access inside health systems and clinics.
- Med affairs / sales access scheduling
- Provider education logistics
Key facts
- HQ: 225 Dyer St, Providence, RI
- Healthcare provider ↔ life science engagement platform
- Slater Technology Fund publicly associated historically as board observer/investor network
Competitive landscape
Edge: Workflow focus on regulated industry access inside provider orgs.
-
Veeva adjacent
Life sciences CRM/content giant.
-
IQVIA digital engagement adjacent
HCP engagement suites.
Industries
FAQs about RxVantage
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.